Pharmacological FABP inhibition (BMS-309403) or siRNA targeting FABP5/7 interrupts intercellular lipid transfer between neurons and microglia. Pathway-proximal intervention that addresses the lipid relay mechanism directly. Plausible therapeutic hedge requiring cell-type-specific validation and construct deconvolution to address redundancy concerns.
Pharmacological NLRP3 inhibition via MCC950 breaks the lipid-inflammasome feedback loop that perpetuates microglial activation. Does not require upstream lipid normalization; directly tests whether established inflammation is reversible. Most clinically actionable surviving hypothesis with tractable medicinal chemistry and established translational pathway.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
# Critical Evaluation of Hypotheses Addressing Neuronal AMPK-Microglial Inflammation Reversal
## Overarching Framing
The knowledge gap concerns whether restoring neuronal AMPK reverses established m...
Persona-Domain Expert
**Bottom Line**
If the question is strictly the gap, the only decisive experiment is **adult, neuron-specific AMPK restoration after microglial inflammation is already established**. That is the best...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Neuronal AMPK Restoration (H1): Direct Reversibility Test",
"description": "Constitutive neuronal AMPK activation via AAV9-Synapsin-AMPKα...
# Critical Evaluation of Hypotheses Addressing Neuronal AMPK-Microglial Inflammation Reversal
## Overarching Framing
The knowledge gap concerns whether restoring neuronal AMPK reverses established m...
Persona-Domain Expert
**Bottom Line**
If the question is strictly the gap, the only decisive experiment is **adult, neuron-specific AMPK restoration after microglial inflammation is already established**. That is the best...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Neuronal AMPK Restoration (H1): Direct Reversibility Test",
"description": "Constitutive neuronal AMPK activation via AAV9-Synapsin-AMPKα...